U R Fölsch| - JoVE Visualize

Showing results (211-220 of 226) with videos related to

Pageof 23

Sort By:

European Journal of Clinical Investigation|October 9, 2001

CCK-B/gastrin receptors in human colorectal cancerF Schmitz, J M Otte, H U Stechele, et al.

Gut|April 1, 1985

Comparative radiological and morphological study of human pancreas. Pancreatitis like changes in postmortem ductograms and their morphological pattern. Possible implication for ERCPP Schmitz-Moormann, G W Himmelmann, J W Brandes, et al.

Helicobacter|February 15, 2000

Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different durationH G Dammann, U R Fölsch, E G Hahn, et al.

The American Journal of Physiology|January 1, 1997

Relaxant effect of xenin on rat ileum is mediated by apamin-sensitive neurotensin-type receptorsA Clemens, S Katsoulis, R Nustede, et al.

Regulatory Peptides|April 1, 1999

Biological activity of GLP-1-analogues with N-terminal modificationsE G Siegel, B Gallwitz, G Scharf, et al.

Oncogene|August 21, 2007

The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibitionS Sebens Müerköster, A V Rausch, A Isberner, et al.

The European Respiratory Journal|March 2, 2005

Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantationR H Hübner, S Meffert, U Mundt, et al.

Digestion|January 1, 1990

Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in manW E Schmidt, W Creutzfeldt, M Höcker, et al.

The American Journal of Physiology|February 1, 1991

Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumideW E Schmidt, W Creutzfeldt, A Schleser, et al.

Oncogene|September 8, 2009

Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.

Pageof 23

Showing results (211-220 of 226) with videos related to

Sort By:

Pageof 23

European Journal of Clinical Investigation|October 9, 2001

CCK-B/gastrin receptors in human colorectal cancerF Schmitz, J M Otte, H U Stechele, et al.

Gut|April 1, 1985

Comparative radiological and morphological study of human pancreas. Pancreatitis like changes in postmortem ductograms and their morphological pattern. Possible implication for ERCPP Schmitz-Moormann, G W Himmelmann, J W Brandes, et al.

Helicobacter|February 15, 2000

Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different durationH G Dammann, U R Fölsch, E G Hahn, et al.

The American Journal of Physiology|January 1, 1997

Relaxant effect of xenin on rat ileum is mediated by apamin-sensitive neurotensin-type receptorsA Clemens, S Katsoulis, R Nustede, et al.

Regulatory Peptides|April 1, 1999

Biological activity of GLP-1-analogues with N-terminal modificationsE G Siegel, B Gallwitz, G Scharf, et al.

Oncogene|August 21, 2007

The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibitionS Sebens Müerköster, A V Rausch, A Isberner, et al.

The European Respiratory Journal|March 2, 2005

Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantationR H Hübner, S Meffert, U Mundt, et al.

Digestion|January 1, 1990

Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in manW E Schmidt, W Creutzfeldt, M Höcker, et al.

The American Journal of Physiology|February 1, 1991

Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumideW E Schmidt, W Creutzfeldt, A Schleser, et al.

Oncogene|September 8, 2009

Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.

Pageof 23